-
Louis's Most Recent
Articles
No, the Meta Materials Spin-Off Is NOT a Reason to Buy MMAT Stock.
MMAT stock investors shouldn't consider Meta Materials a winner solely based on its revenue growth, as profitability remains elusive.
Quant Ratings Updated on 59 Stocks
Volatility ticked up on Monday, with the broader indices falling more than 1% on news of the protests at the Foxconn factory Zhengzhou in China over the country’s draconian COVID-19 rules.
Is GOOG Stock About to Turn a Corner? Not So Fast
With recent developments doing little to change the situation, there's clearly still no rush to enter/add to a position.
Short-Sellers Were Right About Mullen Automotive Stock
Mullen's lack of recent quarterly reports - and the company's inability to turn a profit - should make MULN stock investors think twice.
Steer Clear of SOFI Stock After Latest Student Loan News
With the student loan moratorium now extended further, it may take more time for SOFI stock to make, at best, a moderate leap higher. Steering clear remains the best move.
Why the Depressed CSCO Stock Price Is a Real Treat for Investors
CSCO stock traders might bristle at the word "restructuring," but Cisco is really just right-sizing as it posts encouraging financial data.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 59 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Reach for Big Yield With Lithium Play SQM Stock
Look to Chile for robust lithium output as SQM stock provides premium exposure to a production giant with outstanding financials.
Steer Clear of These 10 Dividend Stocks
Here are 10 examples of dividend stocks with high dividend yields but also hold an F-rating in Dividend Grader, indicating that you should stay far, far away from.
Lithium Americas Spinoff Will Speed Up LAC Stock’s Liftoff
As the spinoff plan increases its upside potential, feel free to consider LAC stock worthy of a small, speculative position.
3 Reasons to Turn Any LLY Stock Skeptic Into a Believer
LLY stock has rewarded its investors with impressive growth in 2022, and earnings beats suggest that Eli Lilly will continue to deliver.
3 Things Making CVS Stock More Attractive Right Now
With this share repurchase announcement, there's now more reason to hold onto an existing CVS stock position if you already own it, and more reason to buy it, if it's not currently in your portfolio.
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
PFE stock still remains a dirt-cheap dividend darling, even after across-the-board earnings beats and lifted guidance.
Quant Ratings Updated on 77 Stocks
After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health over the weekend, I decided to revise my Portfolio Grader recommendations for 77 big blue chips.
There Could Be High Rewards for High-Risk HUDI Stock
In hindsight, entering a small speculative position in HUDI stock, whether now or on further weakness, could prove in hindsight to be a profitable move.
What Warren Buffett Sees in OXY Stock
If Warren Buffett likes OXY stock, there's probably a good reason for this. Perhaps a deep-dive into the data will support the bull thesis.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 77 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
The Salesforce Stock Sell-Off Still Has a Ways to Go
For now, it's best to assume a recovery will only happen when the downturn in enterprise IT spending fully plays out. With plenty of time until that happens, there's no reason to rush into CRM stock today.
